Estrella Biopharma, Inc.
1 clinical trials · Sponsor
◉ Watch Estrella Biopharma, Inc.
| Record | Firm | Date |
|---|---|---|
| T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) (NCT06343311) | Estrella Biopharma, Inc. | 2024-06-01 |
Track Estrella Biopharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.